These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

826 related items for PubMed ID: 28293374

  • 41. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L, Böör A, Sasinka M.
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [Abstract] [Full Text] [Related]

  • 42. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M, Owczarek D, Finke D, Nowicki M.
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [Abstract] [Full Text] [Related]

  • 43. The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review.
    Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS.
    Health Technol Assess; 2007 Apr; 11(21):iii-iv, ix-xi, 1-93. PubMed ID: 17537341
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF, Brodeh J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Sabry A, El-Husseini A, El-Dahshan K, Sobh M.
    Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
    Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
    [Abstract] [Full Text] [Related]

  • 56. Treatment of childhood nephrotic syndrome.
    Mendoza SA, Tune BM.
    J Am Soc Nephrol; 1992 Oct; 3(4):889-94. PubMed ID: 1450365
    [Abstract] [Full Text] [Related]

  • 57. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E, Ksiazek J, Kryński J, Wyszyńska T.
    Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN, Hotchandani HM, Zubair AM, Lohana NC, Veerwani NR.
    BMC Nephrol; 2019 Jul 03; 20(1):239. PubMed ID: 31269922
    [Abstract] [Full Text] [Related]

  • 60. Successful treatment of a patient with nephrotic syndrome associated with chronic lymphocytic leukemia.
    Takahashi F, Ogawa Y, Hasebe N, Natori S, Tokusashi Y, Miyokawa N, Kikuchi K.
    Intern Med; 2000 Mar 03; 39(3):256-9. PubMed ID: 10772132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.